Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5932)
All Articles published online
|
Publishing Process of This Article
|
Oct 21, 2018 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang CY, Wei LQ, Niu HZ, Gao WQ, Wang T, Chen SJ. Agitation thrombolysis combined with catheter-directed thrombolysis for the treatment of non-cirrhotic acute portal vein thrombosis. World J Gastroenterol 2018; 24(39): 4482-4488 [PMID: 30357003 DOI: 10.3748/wjg.v24.i39.4482] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i39/4482.htm |
| Number | Citing Articles |
| 1 |
Martin Rössle, Dominik Bettinger, Jonel Trebicka, Christoph Klinger, Michael Praktiknjo, Lukas Sturm, Karel Caca, Victoria Therese Mücke, Klaus Radecke, Cornelius Engelmann, Alexander Zipprich, Hauke Heinzow, Carsten Meyer, Ulrich Tappe, Beate Appenrodt, Arthur Schmidt, Christian Lange, Christian Strassburg, Stefan Zeuzem, Daniel Grandt, Hartmut Schmidt, Joachim Moessner, Thomas Berg, Frank Lammert, Robert Thimme, Michael Schultheiß. A prospective, multicentre study in acute non‐cirrhotic, non‐malignant portal vein thrombosis: comparison of medical and interventional treatment. Alimentary Pharmacology & Therapeutics 2020; 52(2): 329 doi: 10.1111/apt.15811
|
| 2 |
Qiuye Cheng, Kevin Tree. Systematic Review of Thrombolysis Therapy in the Management of Non-Cirrhosis-Related Portal Vein Thrombosis. Journal of Gastrointestinal Surgery 2021; 25(6): 1579 doi: 10.1007/s11605-020-04624-4
|
| 3 |
Tuba Baydas, Necat Irem Abdulhayoglu, Emine Mutlu, Leila Kianifard, Metin Basaranoglu. Portal Vein Thrombosis. 2021; : 103 doi: 10.1007/978-981-33-6538-4_8
|
| 4 |
Qiang Wei, Shengmin Mei, Zhifei Fu, Xiaodong Wang, Chengzuo Han, Jun Chen, Peng Liu, Bin Chen, Xin Fang, Changku Jia, Shusen Zheng, Xiao Xu. Preventive use of low molecular weight heparin in portal vein system thrombosis after splenectomy without portal hypertension. Heliyon 2022; 8(12): e12482 doi: 10.1016/j.heliyon.2022.e12482
|
| 5 |
Aliaksei Salei, Husameddin El Khudari, Benjamin J. McCafferty, Rakesh K. Varma. Portal Interventions in the Setting of Venous Thrombosis or Occlusion. RadioGraphics 2022; 42(6): 1690 doi: 10.1148/rg.220020
|
| 6 |
Dominique-Charles Valla. Hepatic vein thrombosis and PVT: A personal view on the contemporary development of ideas. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000246
|
| 7 |
Aurora Lemma, Fredrik Åberg, Heikki Mäkisalo, Pirkka Vikatmaa, Panu Mentula, Ari Leppäniemi, Ville Sallinen. Predictors of insufficient recanalization and portal hypertensive complications after treatment of non-cirrhotic, non-malignant portal vein thrombosis – a population-based study. Scandinavian Journal of Gastroenterology 2020; 55(11): 1324 doi: 10.1080/00365521.2020.1823465
|
| 8 |
Lizbeth Hu, Janet Adegboye, Angela Tung Chang, Marie Hanna, Kellie Jaremko. Uncomplicated epidural removal in a patient on a therapeutic heparin infusion: a case report. Regional Anesthesia & Pain Medicine 2024; : rapm-2024-105577 doi: 10.1136/rapm-2024-105577
|
| 9 |
Qiang Wei, Shengmin Mei, Chengzuo Han, Zhifei Fu, Xiaodong Wang, Jun Chen, Peng Liu, Bin Chen, Xin Fang, Changku Jia, Shusen Zheng, Xiao Xu. Preventive Use of Low Molecular Weight Heparin in Portal Vein System Thrombosis after Splenectomy Without Portal Hypertension. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.3999162
|
| 10 |
Fang-Bo Gao, Le Wang, Wen-Xiu Zhang, Xiao-Dong Shao, Xiao-Zhong Guo, Xing-Shun Qi. Successful treatment of acute symptomatic extensive portal venous system thrombosis by 7-day systemic thrombolysis. World Journal of Gastrointestinal Surgery 2022; 14(9): 1082-1085 doi: 10.4240/wjgs.v14.i9.1082
|
| 11 |
Dan Zhang, Shixue Xu, Yulong Tian, Xingshun Qi. Editorial: acute non‐cirrhotic and non‐malignant portal vein thrombosis—who should be candidates for interventional treatment?. Alimentary Pharmacology & Therapeutics 2020; 52(4): 725 doi: 10.1111/apt.15902
|
| 12 |
Dominique C. Valla. Recent developments in the field of vascular liver diseases. Liver International 2020; 40(S1): 142 doi: 10.1111/liv.14348
|
| 13 |
Umut Oguslu, Sadık Ahmet Uyanik, Halime Çevik Cenkeri, Eray Atli, Birnur Yilmaz, Burçak Gümüş. Transhepatic Pharmacomechanical Thrombectomy of Symptomatic Acute Noncirrhotic, Nonmalignant Portomesenteric Venous Thrombosis: Midterm Results. American Journal of Roentgenology 2021; 217(2): 418 doi: 10.2214/AJR.20.23150
|
| 14 |
Fangbo Gao, Le Wang, Jiahui Pan, Yuhang Yin, Jing Wang, Xiangbo Xu, Shixue Xu, Andrea Mancuso, Xingshun Qi. Efficacy and safety of thrombolytic therapy for portal venous system thrombosis: A systematic review and meta‐analysis. Journal of Internal Medicine 2023; 293(2): 212 doi: 10.1111/joim.13575
|
| 15 |
Nabeel Mansour, Osman Öcal, Mirjam Gerwing, Michael Köhler, Sinan Deniz, Hauke Heinzow, Christian Steib, Martin K. Angele, Max Seidensticker, Jens Ricke, Moritz Wildgruber. Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access. Abdominal Radiology 2022; 47(3): 1177 doi: 10.1007/s00261-022-03411-w
|
| 16 |
C. Steib, M. Guba, M. Seidensticker. Pfortaderthrombosen – therapeutische Möglichkeiten. Der Gastroenterologe 2021; 16(2): 79 doi: 10.1007/s11377-021-00507-5
|
| 17 |
Tatsuo Ueda, Hidemasa Saito, Sayaka Shirai, Fumie Sugihara, Ryutaro Fujitsuna, Taiga Matsumoto, Hiromitsu Hayashi, Shin-ichiro Kumita. Endovascular Treatment for Acute Portal Vein Thrombosis. Interventional Radiology 2024; doi: 10.22575/interventionalradiology.2023-0027
|
| 18 |
Nabeel Mansour, Kathrin Heinrich, Danmei Zhang, Michael Winkelmann, Maria Ingenerf, Lukas Gold, Konstantin Klambauer, Martina Rudelius, Frederick Klauschen, Michael von Bergwelt-Baildon, Jens Ricke, Volker Heinemann, C. Benedikt Westphalen, Wolfgang G. Kunz. Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation. Cancer Imaging 2024; 24(1) doi: 10.1186/s40644-024-00708-5
|